MedPath

Passive Stretching in Peripheral Arterial Disease Patients

Phase 2
Recruiting
Conditions
Peripheral Arterial Disease
Walking, Difficulty
Inflammation
Interventions
Device: Calf Plantar flexion
Dietary Supplement: Dietary nitrate
Registration Number
NCT06420752
Lead Sponsor
University of Wisconsin, La Crosse
Brief Summary

Peripheral artery disease (PAD) leads to higher mortality rates and strains healthcare systems due to increased costs. It causes leg pain during walking due to reduced blood flow. Nitric oxide (NO) deficiency contributes to vascular issues in PAD, with few effective treatments available. Passive calf muscle stretching boosts NO levels, vascular health, and walking ability in PAD patients. However, the inflammatory processes underlying these improvements are unclear. This study aims to track inflammatory markers and cardiovascular changes during 12 weeks of passive stretching. Additionally, combining stretching with dietary nitrate could further enhance walking capacity by reducing reactive oxygen species. The study will monitor inflammation, vascular function, and oxidative capacity to understand the effects on functional ability in PAD patients. This research is crucial for improving physical function and addressing exercise intolerance in PAD.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria

Ankle-brachial index of 0.90 or less Stable condition for at least 3 months

Exclusion Criteria

Habitual exercise or cardiovascular rehabilitation program during the past 3 months Critical limb ischemia, amputation, or leg pain at rest Major surgery or lower extremity revascularization in the last 3 months Heart Failure Kidney disease Beet allergy Crohn's Current smoker

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Functional Walking capacityCalf Plantar flexionPassive stretching of the calf muscles 5 days per week for 12-weeks
Functional Walking capacityDietary nitratePassive stretching of the calf muscles 5 days per week for 12-weeks
InflammationDietary nitrateBlood and muscle biopsy samples pre/post passive stretching to assess local and systemic inflammation
InflammationCalf Plantar flexionBlood and muscle biopsy samples pre/post passive stretching to assess local and systemic inflammation
Primary Outcome Measures
NameTimeMethod
Functional capacity12-14 weeks

6-minute walking distance will be assessed prior to an at various time points during the 12-week study

Secondary Outcome Measures
NameTimeMethod
Vascular function12-14 weeks

Large vessel (flow-mediated vasodilation) and small vessel (Near-infrared spectroscopy on the calf) will be measured prior to and at various time points during the 12-week study.

Inflammatory markers12-14 weeks

Blood and calf muscle biopsy will be used to assess various inflammatory markers pre/post treatment.

Trial Locations

Locations (1)

University of Wisconsin La Crosse

🇺🇸

La Crosse, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath